2017
DOI: 10.1007/s10545-017-0089-4
|View full text |Cite
|
Sign up to set email alerts
|

Isolated sulfite oxidase deficiency

Abstract: Isolated sulfite oxidase deficiency (ISOD) is a life-threatening, autosomal recessive disease characterized by severe neurological impairment. As no long-term effective treatment is available, distinction from other treatable diseases, such as molybdenum cofactor deficiency (MoCD) type A, should be made. We reviewed 47 patients (45 previously reported in the literature). Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

2
64
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 57 publications
(82 citation statements)
references
References 33 publications
2
64
0
Order By: Relevance
“…Isolated sulfite oxidase deficiency (ISOD) is a rare, autosomal recessive, neurometabolic disorder caused by mutations in the SUOX gene that encodes sulfite oxidase 1 . The sulfite oxidase enzyme catalyzes the conversion of toxic sulfite (SO 3 2-) to nontoxic sulfate (SO 4 2-) in the final step of sulfur-containing amino acid catabolism 1 .…”
mentioning
confidence: 99%
See 4 more Smart Citations
“…Isolated sulfite oxidase deficiency (ISOD) is a rare, autosomal recessive, neurometabolic disorder caused by mutations in the SUOX gene that encodes sulfite oxidase 1 . The sulfite oxidase enzyme catalyzes the conversion of toxic sulfite (SO 3 2-) to nontoxic sulfate (SO 4 2-) in the final step of sulfur-containing amino acid catabolism 1 .…”
mentioning
confidence: 99%
“…Isolated sulfite oxidase deficiency (ISOD) is a rare, autosomal recessive, neurometabolic disorder caused by mutations in the SUOX gene that encodes sulfite oxidase 1 . The sulfite oxidase enzyme catalyzes the conversion of toxic sulfite (SO 3 2-) to nontoxic sulfate (SO 4 2-) in the final step of sulfur-containing amino acid catabolism 1 . Patients typically present with neonatal intractable seizures, encephalopathy, abnormal muscle tone (axial hypotonia, peripheral hypertonia) and diffuse brain abnormalities (multicystic leukoencephalopathy resembling hypoxic ischemic changes) 1 .…”
mentioning
confidence: 99%
See 3 more Smart Citations